Literature DB >> 430481

Serotonin receptor binding affinities of tryptamine analogues.

R A Glennon, P K Gessner.   

Abstract

Using a rat fundus model, the serotonin (5-HT) receptor binding affinities of 27 tryptamine analogues were determined. Factors which might affect affinity were examined, e.g., lipids solubility, as reflected by partition coefficient, and pKa. Structure-activity relationships were developed and are discussed in terms of substituents on the terminal amine, the side chain, and the indole 1 position, the 5 position, and at other positions on the indolic nucleus. If lipid solubility and metabolism can be accounted for, there appears to be a parallelism between 5-HT receptor binding affinities and the hallucinogenic (psychotomimetic) potencies of several of these compounds.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 430481     DOI: 10.1021/jm00190a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

Review 2.  The mechanism of receptor development as implied by hormonal imprinting studies on unicellular organisms.

Authors:  P Kovács
Journal:  Experientia       Date:  1986-07-15

3.  Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.

Authors:  J Koerner; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Proceedings of the British Pharmacological Society. University of Southampton, 17th-19th July 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

5.  Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2011-04-04       Impact factor: 3.922

6.  In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.

Authors:  K Yanai; T Ido; K Ishiwata; J Hatazawa; T Takahashi; R Iwata; T Matsuzawa
Journal:  Eur J Nucl Med       Date:  1986

7.  Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities.

Authors:  R A Glennon; R Young; J A Rosecrans; M J Kallman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 8.  1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Authors:  Sylvana Vilca-Melendez; Malin V Uthaug; Julian L Griffin
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

9.  Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.

Authors:  Claudius Lenz; Sebastian Dörner; Felix Trottmann; Christian Hertweck; Alexander Sherwood; Dirk Hoffmeister
Journal:  Chembiochem       Date:  2022-05-18       Impact factor: 3.461

10.  Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives.

Authors:  N Milne; P Thomsen; N Mølgaard Knudsen; P Rubaszka; M Kristensen; I Borodina
Journal:  Metab Eng       Date:  2020-03-26       Impact factor: 9.783

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.